{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:58:23Z","timestamp":1785772703492,"version":"3.56.0"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018978","name":"Indian Institute of Technology Ropar","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018978","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.intimp.2023.110210","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T12:33:51Z","timestamp":1682339631000},"page":"110210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Future perspectives of emerging novel drug targets and immunotherapies to control drug addiction"],"prefix":"10.1016","volume":"119","author":[{"given":"Jonaid Ahmad","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed N.","family":"Agrewala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.110210_b0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/add.16001","article-title":"Emotion regulation in substance use disorders: a systematic review and meta-analysis","volume":"118","author":"Stellern","year":"2023","journal-title":"Addiction"},{"key":"10.1016\/j.intimp.2023.110210_b0010","unstructured":"Drugs Available online: https:\/\/www.who.int\/health-topics\/drugs-psychoactive#tab=tab_2 (accessed on Feb 28, 2023)."},{"key":"10.1016\/j.intimp.2023.110210_b0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejphar.2005.09.038","article-title":"Novel pharmacotherapeutic targets for the management of drug addiction","volume":"526","author":"Heidbreder","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110210_b0020","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/s41401-018-0180-x","article-title":"Drug addiction: a curable mental disorder?","volume":"39","author":"Liu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2023.110210_b0025","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00213-016-4484-6","article-title":"Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction","volume":"234","author":"Koob","year":"2017","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.intimp.2023.110210_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2017.01.014","article-title":"Opioid Use Disorder: A Desperate Need for Novel Treatments","volume":"81","author":"Fuehrlein","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.intimp.2023.110210_b0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mus.880140802","article-title":"Aaem minimonograph #11: Needle examination in clinical electromyography","volume":"14","author":"Oaube","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.intimp.2023.110210_b0040","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.nlm.2011.02.014","article-title":"Aberrant Learning and Memory in Addiction","volume":"96","author":"Torregrossa","year":"2011","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.intimp.2023.110210_b0045","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.85280","article-title":"Aberrant Brain Neuroplasticity and Function in Drug Addiction: A Focus on Learning-Related Brain Regions","author":"Sampedro-Piquero","year":"2019","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0050","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nrn2234","article-title":"Synaptic plasticity and addiction","volume":"8","author":"Kauer","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.molmed.2008.06.004","article-title":"Epigenetic mechanisms in drug addiction","volume":"14","author":"Renthal","year":"2008","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2023.110210_b0060","doi-asserted-by":"crossref","first-page":"11042","DOI":"10.1073\/pnas.191352698","article-title":"DeltaFosB: a sustained molecular switch for addiction","volume":"98","author":"EJ","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2023.110210_b0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.molbrainres.2004.05.014","article-title":"DeltaFosB: a molecular switch for long-term adaptation in the brain","volume":"132","author":"McClung","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.intimp.2023.110210_b0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMp1704633","article-title":"Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern?","volume":"377","author":"Goodman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2023.110210_b0075","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/syn.10198","article-title":"Differential gene expression in the rat caudate putamen after \u201cbinge\u201d cocaine administration: advantage of triplicate microarray analysis","volume":"48","author":"Yuferov","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.intimp.2023.110210_b0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0896-6273(04)00159-X","article-title":"Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking","volume":"42","author":"Bowers","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2023.110210_b0085","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/nn1929","article-title":"Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse","volume":"10","author":"Graham","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0090","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neuron.2005.09.023","article-title":"Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum","volume":"48","author":"Kumar","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2023.110210_b0095","doi-asserted-by":"crossref","first-page":"19186","DOI":"10.1073\/pnas.0509735102","article-title":"CREB-binding protein controls response to cocaine by acetylating histones at the fosB promoter in the mouse striatum","volume":"102","author":"Levine","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2023.110210_b0100","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuron.2007.09.032","article-title":"Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli","volume":"56","author":"Renthal","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2023.110210_b0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.biopsych.2020.08.005","article-title":"Epigenetic mechanisms in drug relapse","volume":"89","author":"Werner","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.intimp.2023.110210_b0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuropharm.2018.08.030","article-title":"The histone demethylase KDM6B in the medial prefrontal cortex epigenetically regulates cocaine reward memory","volume":"141","author":"Zhang","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2023.110210_b0115","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12808","article-title":"Role of BRD4 phosphorylation in the nucleus accumbens in relapse to cocaine-seeking behavior in mice","volume":"25","author":"Guo","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.intimp.2023.110210_b0120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00213-012-2750-9","article-title":"Learning to forget: manipulating extinction and reconsolidation processes to treat addiction","volume":"226","author":"Torregrossa","year":"2013","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.intimp.2023.110210_b0125","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1111\/j.1460-9568.2010.07249.x","article-title":"The psychological and neurochemical mechanisms of drug memory reconsolidation: implications for the treatment of addiction","volume":"31","author":"Milton","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0130","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"Whiteford","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2023.110210_b0135","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0242","article-title":"Assessment of Annual Cost of Substance Use Disorder in US Hospitals","volume":"4","author":"Peterson","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.intimp.2023.110210_b0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jsat.2007.04.003","article-title":"Economic costs of drug abuse: Financial, cost of illness, and services","volume":"34","author":"Cartwright","year":"2008","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.intimp.2023.110210_b0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/107755870005700106","article-title":"The cost of health conditions in a health maintenance organization","volume":"57","author":"Ray","year":"2000","journal-title":"Med. Care Res. Rev."},{"key":"10.1016\/j.intimp.2023.110210_b0150","unstructured":"Weisner C, Mertens J, Parthasarathy S, Moore C, Hunkeler EM, Hu T, Selby JV. The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens. Health Serv Res. 2000 Oct;35(4):791-812. PMID: 11055449; PMCID: PMC1089153."},{"key":"10.1016\/j.intimp.2023.110210_b0155","unstructured":"Rosenbach, L. Margo, H. Huber. Joyce, Utilization and cost of drug abuse treatment under Medicaid: an in-depth study of Washington State, NIDA services research monograph (NIN publ. no. 94-3543 (1994) 51\u201394."},{"key":"10.1016\/j.intimp.2023.110210_b0160","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1176\/ps.49.12.1573","article-title":"Costs and utilization of substance abuse care in a privately insured population under managed care","volume":"49","author":"Schoenbaum","year":"1998","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.intimp.2023.110210_b0165","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/S2542-5196(20)30075-9","article-title":"The burden of disease in Saudi Arabia 1990\u20132017: results from the Global Burden of Disease Study 2017","volume":"4","author":"Tyrovolas","year":"2020","journal-title":"Lancet Planet. Heal."},{"key":"10.1016\/j.intimp.2023.110210_b0170","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jfda.2013.09.038","article-title":"Family and social aspects of substance use disorders and treatment","volume":"21","author":"Daley","year":"2013","journal-title":"J. food drug Anal."},{"key":"10.1016\/j.intimp.2023.110210_b0175","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1111\/bcp.14112","article-title":"Immune-mediated adverse reactions to vaccines","volume":"85","author":"Stone","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110210_b0180","doi-asserted-by":"crossref","unstructured":"Blasco, R.; Ortego, J.; Marin-Lopez, A.; Kaur, G.; Singh, S.; Nanda, S.; Zafar, M.A.; Malik, J.A.; Arshi, M.U.; Lamba, T.; et al. Fiction and Facts about BCG Imparting Trained Immunity against COVID-19. Vaccines 2022, Vol. 10, Page 1006 2022, 10, 1006, doi:10.3390\/VACCINES10071006.","DOI":"10.3390\/vaccines10071006"},{"key":"10.1016\/j.intimp.2023.110210_b0185","unstructured":"CDC - Page Not Found Available online: https:\/\/www.cdc.gov\/globalhealth\/infographics\/immunization\/global_impact_of_vaccines.htm: (accessed on Aug 1, 2022)."},{"key":"10.1016\/j.intimp.2023.110210_b0190","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4161\/hv.27243","article-title":"Epidemiology of vaccine hesitancy in the United States","volume":"9","author":"Siddiqui","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.intimp.2023.110210_b0195","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1016\/j.vaccine.2017.07.061","article-title":"The benefit of the doubt or doubts over benefits? A systematic literature review of perceived risks of vaccines in European populations","volume":"35","author":"Karafillakis","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2023.110210_b0200","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127 Suppl 1","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.intimp.2023.110210_b0205","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1016\/j.vaccine.2011.07.044","article-title":"Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004\u20132009","volume":"29","author":"Williams","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2023.110210_b0210","doi-asserted-by":"crossref","first-page":"7253","DOI":"10.1016\/j.vaccine.2012.09.074","article-title":"Causality assessment of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"30","author":"Loughlin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2023.110210_b0215","first-page":"9","article-title":"Vaccinations and Autoimmune Diseases","author":"Olivieri","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.intimp.2023.110210_b0220","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"The lancet. Psychiatry"},{"key":"10.1016\/j.intimp.2023.110210_b0225","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2217\/fnl.10.14","article-title":"Neurobiology of dysregulated motivational systems in drug addiction","volume":"5","author":"Edwards","year":"2010","journal-title":"Future Neurol."},{"key":"10.1016\/j.intimp.2023.110210_b0230","first-page":"18","article-title":"Involvement of cAMP-Dependent Protein Kinase in the Nucleus Accumbens in Cocaine Self-Administration and Relapse of Cocaine-Seeking Behavior","volume":"1998","author":"Self","year":"1848","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0235","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1126\/science.282.5397.2272","article-title":"Regulation of cocaine reward by CREB","volume":"282","author":"Carlezon","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.intimp.2023.110210_b0240","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nn1578","article-title":"Is there a common molecular pathway for addiction?","volume":"8","author":"Nestler","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0245","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/gb-2014-15-4-r65","article-title":"Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens","volume":"15","author":"Feng","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.intimp.2023.110210_b0250","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuron.2008.10.055","article-title":"Translational control of long-lasting synaptic plasticity and memory","volume":"61","author":"Costa-Mattioli","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.intimp.2023.110210_b0255","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jnc.12725","article-title":"mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse","volume":"130","author":"Neasta","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2023.110210_b0260","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1007\/s00213-014-3491-8","article-title":"Reactivation of cocaine reward memory engages the Akt\/GSK3\/mTOR signaling pathway and can be disrupted by GSK3 inhibition","volume":"231","author":"Shi","year":"2014","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.intimp.2023.110210_b0265","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuro.2021.02.005","article-title":"Effect of suvorexant on morphine tolerance and dependence in mice: Role of NMDA, AMPA ERK and CREB proteins","volume":"84","author":"Esmaili-Shahzade-Ali-Akbari","year":"2021","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.intimp.2023.110210_b0270","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.neubiorev.2009.02.005","article-title":"The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction","volume":"33","author":"Guo","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.intimp.2023.110210_b0275","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1523\/JNEUROSCI.2875-12.2016","article-title":"Nucleus Accumbens AMPA Receptors Are Necessary for Morphine-Withdrawal-Induced Negative-Affective States in Rats","volume":"36","author":"Russell","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0280","doi-asserted-by":"crossref","first-page":"27662","DOI":"10.1074\/jbc.M502593200","article-title":"Mu and kappa opioid receptors activate ERK\/MAPK via different protein kinase C isoforms and secondary messengers in astrocytes","volume":"280","author":"Belcheva","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2023.110210_b0285","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pain.2007.03.028","article-title":"Opioid dependence and addiction during opioid treatment of chronic pain","volume":"129","author":"Ballantyne","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.intimp.2023.110210_b0290","doi-asserted-by":"crossref","unstructured":"Cheron, J.; De Kerchove D\u2019exaerde, A. Drug addiction: from bench to bedside., doi:10.1038\/s41398-021-01542-0.","DOI":"10.1038\/s41398-021-01542-0"},{"key":"10.1016\/j.intimp.2023.110210_b0295","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201745089","article-title":"Deletion of Maged1 in mice abolishes locomotor and reinforcing effects of cocaine","volume":"19","author":"De Backer","year":"2018","journal-title":"EMBO Rep."},{"key":"10.1016\/j.intimp.2023.110210_b0300","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nature13257","article-title":"Contrasting forms of cocaine-evoked plasticity control components of relapse","volume":"509","author":"Pascoli","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110210_b0305","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1260776","article-title":"Addiction therapy. Refining deep brain stimulation to emulate optogenetic treatment of synaptic pathology","volume":"347","author":"Creed","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.intimp.2023.110210_b0310","first-page":"7513","article-title":"GPRIN3 Controls Neuronal Excitability","volume":"39","author":"Karadurmus","year":"2019","journal-title":"Morphology, and Striatal-Dependent Behaviors in the Indirect Pathway of the Striatum."},{"key":"10.1016\/j.intimp.2023.110210_b0315","doi-asserted-by":"crossref","first-page":"8794","DOI":"10.1523\/JNEUROSCI.2989-12.2013","article-title":"FACS array profiling identifies Ecto-5\u2019 nucleotidase as a striatopallidal neuron-specific gene involved in striatal-dependent learning","volume":"33","author":"Ena","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0320","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/cne.10783","article-title":"Overlapping distributions of orexin\/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress","volume":"464","author":"Baldo","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.intimp.2023.110210_b0325","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1523\/JNEUROSCI.2761-05.2006","article-title":"Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine","volume":"26","author":"Narita","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0330","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature04071","article-title":"A role for lateral hypothalamic orexin neurons in reward seeking","volume":"437","author":"Harris","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110210_b0335","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1471-4159.2007.04748.x","article-title":"Long-lasting up-regulation of orexin receptor type 2 protein levels in the rat nucleus accumbens after chronic cocaine administration","volume":"103","author":"Zhang","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2023.110210_b0340","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/7854_2016_57","article-title":"A Decade of Orexin\/Hypocretin and Addiction: Where Are We Now?","volume":"33","author":"James","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0345","doi-asserted-by":"crossref","unstructured":"Calipari ES, Espa\u00f1a RA. Hypocretin\/orexin regulation of dopamine signaling: implications for reward and reinforcement mechanisms. Front Behav Neurosci. 2012 Aug 21;6:54. doi: 10.3389\/fnbeh.2012.00054. PMID: 22933994; PMCID: PMC3423791.","DOI":"10.3389\/fnbeh.2012.00054"},{"key":"10.1016\/j.intimp.2023.110210_b0350","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.bbrc.2008.11.051","article-title":"Orexin-A increases cell surface expression of AMPA receptors in the striatum","volume":"378","author":"Shin","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2023.110210_b0355","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1523\/JNEUROSCI.23-08-03106.2003","article-title":"Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal","volume":"23","author":"Georgescu","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0360","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/B978-0-444-59489-1.00008-2","article-title":"Hypocretin modulation of drug-induced synaptic plasticity","volume":"198","author":"Baimel","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.intimp.2023.110210_b0365","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainresbull.2017.01.010","article-title":"Intracoerulear microinjection of orexin-A induces morphine withdrawal-like signs in rats","volume":"130","author":"Ghaemi-Jandabi","year":"2017","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.intimp.2023.110210_b0370","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/0976-500X.155496","article-title":"Suvorexant: The first orexin receptor antagonist to treat insomnia","volume":"6","author":"Dubey","year":"2015","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.intimp.2023.110210_b0375","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/hipo.22250","article-title":"Cocaine- or stress-induced metaplasticity of LTP in the dorsal and ventral hippocampus","volume":"24","author":"Keralapurath","year":"2014","journal-title":"Hippocampus"},{"key":"10.1016\/j.intimp.2023.110210_b0380","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.neuroscience.2008.10.059","article-title":"PHOSPHORYLATION OF \u0394FosB MEDIATES ITS STABILITY IN VIVO","volume":"158","author":"Ulery-Reynolds","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.intimp.2023.110210_b0385","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1523\/JNEUROSCI.1611-14.2014","article-title":"Threonine 149 phosphorylation enhances \u0394FosB transcriptional activity to control psychomotor responses to cocaine","volume":"34","author":"Cates","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0390","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrn3111","article-title":"Transcriptional and epigenetic mechanisms of addiction","volume":"12","author":"Robison","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0395","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/syn.20500","article-title":"Distinct patterns of DeltaFosB induction in brain by drugs of abuse","volume":"62","author":"Perrotti","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.intimp.2023.110210_b0400","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/npp.2017.88","article-title":"Cell-Type-Specific Epigenetic Editing at the Fosb Gene Controls Susceptibility to Social Defeat Stress","volume":"43","author":"Hamilton","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.intimp.2023.110210_b0405","doi-asserted-by":"crossref","first-page":"8305","DOI":"10.1523\/JNEUROSCI.0800-19.2019","article-title":"Epigenetic regulation of hippocampal fosb expression controls behavioral responses to cocaine","volume":"39","author":"Gajewski","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0410","doi-asserted-by":"crossref","first-page":"13773","DOI":"10.1523\/JNEUROSCI.2083-15.2015","article-title":"Experience-Dependent Induction of Hippocampal \u0394FosB Controls Learning","volume":"35","author":"Eagle","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0415","doi-asserted-by":"crossref","unstructured":"Liu, P.; Chu, Z.; Lei, G.; Deng, L. sha; Yang, L.; Dang, Y. hui The role of HINT1 protein in morphine addiction: An animal model-based study. 2021, 26, e12897, doi:10.1111\/ADB.12897.","DOI":"10.1111\/adb.12897"},{"key":"10.1016\/j.intimp.2023.110210_b0420","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5181925","article-title":"HINT1 in Neuropsychiatric Diseases: A Potential Neuroplastic Mediator","volume":"2017","author":"Liu","year":"2017","journal-title":"Neural Plast."},{"key":"10.1016\/j.intimp.2023.110210_b0425","first-page":"1285","article-title":"Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia","volume":"66","author":"Guang","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.intimp.2023.110210_b0430","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1007\/s00018-010-0598-x","article-title":"The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation","volume":"68","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.intimp.2023.110210_b0435","doi-asserted-by":"crossref","unstructured":"Fang J, Wang X, He B. Association between common genetic variants in the opioid pathway and smoking behaviors in Chinese men. Behav Brain Funct. 2014 Jan 21;10:2. doi: 10.1186\/1744-9081-10-2. PMID: 24447405; PMCID: PMC3899627.","DOI":"10.1186\/1744-9081-10-2"},{"key":"10.1016\/j.intimp.2023.110210_b0440","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/tpj.2010.41","article-title":"Association of the histidine-triad nucleotide-binding protein-1 (HINT1) gene variants with nicotine dependence","volume":"11","author":"Jackson","year":"2011","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.intimp.2023.110210_b0445","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1089\/ars.2012.5100","article-title":"Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate","volume":"19","author":"S\u00e1nchez-Bl\u00e1zquez","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2023.110210_b0450","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/ars.2014.5993","article-title":"The \u03c31 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control","volume":"22","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2023.110210_b0455","doi-asserted-by":"crossref","first-page":"55840","DOI":"10.18632\/oncotarget.10095","article-title":"Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction","volume":"7","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2023.110210_b0460","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.cellsig.2008.06.015","article-title":"NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of Mu-opioid receptors","volume":"20","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2008","journal-title":"Cell. Signal."},{"key":"10.1016\/j.intimp.2023.110210_b0465","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1089\/ars.2010.3511","article-title":"NO-released zinc supports the simultaneous binding of Raf-1 and PKC\u03b3 cysteine-rich domains to HINT1 protein at the mu-opioid receptor","volume":"14","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2023.110210_b0470","doi-asserted-by":"crossref","first-page":"35458","DOI":"10.18632\/oncotarget.6064","article-title":"The ON:OFF switch, \u03c31R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: implications in neurological disorders","volume":"6","author":"Rodr\u00edguez-Mu\u00f1oz","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2023.110210_b0475","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/ph6020251","article-title":"NMDA Receptor Modulators in the Treatment of Drug Addiction","volume":"6","author":"Tomek","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.intimp.2023.110210_b0480","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0076-6879(04)90029-8","article-title":"Identification and biochemical analysis of GRIN1 and GRIN2","volume":"390","author":"Iida","year":"2004","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.intimp.2023.110210_b0485","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00424-018-2124-1","article-title":"Role of G protein-regulated inducer of neurite outgrowth 3 (GRIN3) in \u03b2-arrestin 2-Akt signaling and dopaminergic behaviors","volume":"470","author":"Mototani","year":"2018","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.intimp.2023.110210_b0490","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0166-2236(90)90106-K","article-title":"The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones","volume":"13","author":"David Smith","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0495","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2011.281","article-title":"Vaccines for Drug Abuse","volume":"91","author":"Shen","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2023.110210_b0500","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1586\/14760584.3.1.11","article-title":"Therapeutic vaccines for substance dependence","volume":"3","author":"Haney","year":"2004","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.intimp.2023.110210_b0505","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.2010.317","article-title":"Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic","volume":"89","author":"Hatsukami","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2023.110210_b0510","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1517\/13543784.16.11.1775","article-title":"Vaccination against nicotine: an emerging therapy for tobacco dependence","volume":"16","author":"Maurer","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.intimp.2023.110210_b0515","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biopsych.2009.08.031","article-title":"Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans","volume":"67","author":"Haney","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.intimp.2023.110210_b0520","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1196\/annals.1441.027","article-title":"Substance abuse vaccines","volume":"1141","author":"Orson","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2023.110210_b0525","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1021\/acs.bioconjchem.1c00179","article-title":"Bivalent Conjugate Vaccine Induces Dual Immunogenic Response That Attenuates Heroin and Fentanyl Effects in Mice","volume":"32","author":"Barrientos","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.intimp.2023.110210_b0530","unstructured":"Esson, K.; Leeder, S.; Initiative, W.T.F. The millennium development goals and tobacco control: an opportunity for global partnership; 2004; ISBN 9241562870."},{"key":"10.1016\/j.intimp.2023.110210_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2019.09.009","article-title":"Wooden chest syndrome: Beware of opioid antagonists, not just agonists","volume":"38","author":"Levine","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.intimp.2023.110210_b0540","doi-asserted-by":"crossref","DOI":"10.1186\/s13011-019-0195-4","article-title":"Higher doses of naloxone are needed in the synthetic opiod era","volume":"14","author":"Moss","year":"2019","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.intimp.2023.110210_b0545","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications","volume":"9","author":"Rzasa Lynn","year":"2018","journal-title":"Ther. Adv. drug Saf."},{"key":"10.1016\/j.intimp.2023.110210_b0550","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10060860","article-title":"Vaccines against Drug Abuse\u2014Are We There Yet?","volume":"10","author":"Bloom","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.intimp.2023.110210_b0555","unstructured":"Clinical Trials of Multivalent Opioid Vaccine Components - Full Text View - ClinicalTrials.gov Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04458545 (accessed on Mar 1, 2023)."},{"key":"10.1016\/j.intimp.2023.110210_b0560","unstructured":"NicVAX for Nicotine Addiction - Clinical Trials Arena Available online: https:\/\/www.clinicaltrialsarena.com\/projects\/nicvaxfornicotineadd\/ (accessed on Aug 2, 2022)."},{"key":"10.1016\/j.intimp.2023.110210_b0565","unstructured":"Sliwi\u0144ska-Mosso\u0144 M, Ziele\u0144 I, Milnerowicz H. New trends in the treatment of nicotine addiction. Acta Pol Pharm. 2014 Jul-Aug;71(4):525-30. PMID: 25272878."},{"key":"10.1016\/j.intimp.2023.110210_b0570","doi-asserted-by":"crossref","unstructured":"Kosten T, Domingo C, Orson F, Kinsey B. Vaccines against stimulants: cocaine and MA. Br J Clin Pharmacol. 2014 Feb;77(2):368-74. doi: 10.1111\/bcp.12115. PMID: 23509915; PMCID: PMC4014030.","DOI":"10.1111\/bcp.12115"},{"key":"10.1016\/j.intimp.2023.110210_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.06.001","article-title":"Development of vaccines to treat opioid use disorders and reduce incidence of overdose","volume":"158","author":"Pravetoni","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2023.110210_b0580","doi-asserted-by":"crossref","unstructured":"Bremer PT, Janda KD. Conjugate Vaccine Immunotherapy for Substance Use Disorder. Pharmacol Rev. 2017 Jul;69(3):298-315. doi: 10.1124\/pr.117.013904. PMID: 28634286; PMCID: PMC5482184.","DOI":"10.1124\/pr.117.013904"},{"key":"10.1016\/j.intimp.2023.110210_b0585","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMsr1706626","article-title":"The Role of Science in Addressing the Opioid Crisis","volume":"377","author":"Volkow","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2023.110210_b0590","first-page":"14","article-title":"Polyvalent vaccines: High-maintenance heroes","author":"Schlingmann","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2023.110210_b0595","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-017-0013-9","article-title":"Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant","volume":"2","author":"Torres","year":"2017","journal-title":"NPJ vaccines"},{"key":"10.1016\/j.intimp.2023.110210_b0600","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1016\/j.vaccine.2012.04.101","article-title":"Co-administration of morphine and oxycodone vaccines reduces the distribution of 6-monoacetylmorphine and oxycodone to brain in rats","volume":"30","author":"Pravetoni","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2023.110210_b0605","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/acs.molpharmaceut.7b00933","article-title":"Enhancing Efficacy and Stability of an Antiheroin Vaccine: Examination of Antinociception, Opioid Binding Profile, and Lethality","volume":"15","author":"Hwang","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.intimp.2023.110210_b0610","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1002\/anie.201511654","article-title":"Combatting Synthetic Designer Opioids: A Conjugate Vaccine Ablates Lethal Doses of Fentanyl Class Drugs","volume":"55","author":"Bremer","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.intimp.2023.110210_b0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyu093","article-title":"A Conjugate Vaccine Attenuates Morphine- and Heroin-Induced Behavior in Rats","volume":"18","author":"Li","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.intimp.2023.110210_b0620","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.176.4039.1143","article-title":"Morphine-3-succinyl\u2013bovine serum albumin: an immunogenic hapten-protein conjugate","volume":"176","author":"Wainer","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.intimp.2023.110210_b0625","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/252708a0","article-title":"Changes in heroin self-administration by a rhesus monkey after morphine immunisation","volume":"252","author":"Bonese","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110210_b0630","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2006.01.047","article-title":"A novel bivalent morphine\/heroin vaccine that prevents relapse to heroin addiction in rodents","volume":"24","author":"Anton","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2023.110210_b0635","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.112.201194","article-title":"Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats","volume":"344","author":"Raleigh","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2023.110210_b0640","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1471-4159.2011.07502.x","article-title":"A morphine\/heroin vaccine with new hapten design attenuates behavioral effects in rats","volume":"119","author":"Li","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.intimp.2023.110210_b0645","doi-asserted-by":"crossref","unstructured":"Valentine JL, Owens SM. Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats. J Pharmacol Exp Ther. 1996 Aug;278(2):717-24. PMID: 8768723.","DOI":"10.1016\/S0022-3565(25)20655-3"},{"key":"10.1016\/j.intimp.2023.110210_b0650","doi-asserted-by":"crossref","unstructured":"Hardin JS, Wessinger WD, Proksch JW, Owens SM. Pharmacodynamics of a monoclonal antiphencyclidine Fab with broad selectivity for phencyclidine-like drugs. J Pharmacol Exp Ther. 1998 Jun;285(3):1113-22. PMID: 9618414.","DOI":"10.1016\/S0022-3565(24)37498-1"},{"key":"10.1016\/j.intimp.2023.110210_b0655","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00000441-200207000-00004","article-title":"Therapeutic Applications of Monoclonal Antibodies","volume":"324","author":"Berger","year":"2002","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.intimp.2023.110210_b0660","doi-asserted-by":"crossref","unstructured":"Owens SM, Mayersohn M. Phencyclidine-specific Fab fragments alter phencyclidine disposition in dogs. Drug Metab Dispos. 1986 Jan-Feb;14(1):52-8. PMID: 2868866.","DOI":"10.1016\/S0090-9556(25)08275-3"},{"key":"10.1016\/j.intimp.2023.110210_b0665","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2307\/4011739","article-title":"Antibodies May Treat Overdoses Addiction","volume":"156","author":"Wu","year":"1999","journal-title":"Sci. News"},{"key":"10.1016\/j.intimp.2023.110210_b0670","doi-asserted-by":"crossref","unstructured":"Owens SM. Antibodies as pharmacokinetic and metabolic modifiers of neurotoxicity. NIDA Res Monogr. 1997;173:259-72. PMID: 9260192.","DOI":"10.1037\/e495572006-015"},{"key":"10.1016\/j.intimp.2023.110210_b0675","doi-asserted-by":"crossref","unstructured":"McClurkan MB, Valentine JL, Arnold L, Owens SM. Disposition of a monoclonal anti-phencyclidine Fab fragment of immunoglobulin G in rats. J Pharmacol Exp Ther. 1993 Sep;266(3):1439-45. PMID: 8371148.","DOI":"10.1016\/S0022-3565(25)39413-9"},{"key":"10.1016\/j.intimp.2023.110210_b0680","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002130050049","article-title":"Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model","volume":"148","author":"Kantak","year":"2000","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.intimp.2023.110210_b0685","doi-asserted-by":"crossref","unstructured":"Baird TJ, Deng SX, Landry DW, Winger G, Woods JH. Natural and artificial enzymes against cocaine. I. Monoclonal antibody 15A10 and the reinforcing effects of cocaine in rats. J Pharmacol Exp Ther. 2000 Dec;295(3):1127-34. PMID: 11082449.","DOI":"10.1016\/S0022-3565(24)39014-7"},{"key":"10.1016\/j.intimp.2023.110210_b0690","doi-asserted-by":"crossref","unstructured":"Briscoe RJ, Jeanville PM, Cabrera C, Baird TJ, Woods JH, Landry DW. A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis. Int Immunopharmacol. 2001 Jun;1(6):1189-98. doi: 10.1016\/s1567-5769(01)00054-6. PMID: 11407313.","DOI":"10.1016\/S1567-5769(01)00054-6"},{"key":"10.1016\/j.intimp.2023.110210_b0695","doi-asserted-by":"crossref","unstructured":"Wirsching, P.; Ashley, J.A.; Lo, C.H.L.; Janda, K.D.; Lerner, R.A. Reactive Immunization. Science (80-.). 1995, 270, 1775, doi:10.1126\/SCIENCE.270.5243.1775.","DOI":"10.1126\/science.270.5243.1775"},{"key":"10.1016\/j.intimp.2023.110210_b0700","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1081-1206(10)62794-9","article-title":"Humanized Antibodies as Potential Therapeutic Drugs","volume":"81","author":"Vaswani","year":"1998","journal-title":"Ann. Allergy, Asthma Immunol."},{"key":"10.1016\/j.intimp.2023.110210_b0705","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nyas.14329","article-title":"Current status of immunotherapies for addiction","volume":"1489","author":"Xu","year":"2021","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2023.110210_b0710","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.774504","article-title":"COVID-19 Vaccine-Related Psychological Stress Among General Public in China","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.intimp.2023.110210_b0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002715","article-title":"Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis","volume":"15","author":"De Crescenzo","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.intimp.2023.110210_b0720","first-page":"87","article-title":"Psychostimulant addiction treatment","author":"Phillips","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2023.110210_b0725","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2023.110210_b0730","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1749-6632.2009.05145.x","article-title":"Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies","volume":"1187","author":"Herin","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2023.110210_b0735","doi-asserted-by":"crossref","unstructured":"D.D. Kiraly, D.M. Walker, E.S. Calipari, B. Labonte, O. Issler, C.J. Pena, E.A. Ribeiro, S.J. Russo, E.J. Nestler, Alterations of the Host Microbiome Affect Behavioral Responses to Cocaine OPEN, 2016 10.1038\/srep35455.","DOI":"10.1038\/srep35455"},{"key":"10.1016\/j.intimp.2023.110210_b0740","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s00213-003-1409-y","article-title":"Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys","volume":"167","author":"Negus","year":"2003","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.intimp.2023.110210_b0745","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","article-title":"Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial","volume":"21","author":"Grabowski","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.intimp.2023.110210_b0750","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00213-020-05563-3","article-title":"Prescription psychostimulants for the treatment of stimulant use disorder: a systematic review and meta-analysis","volume":"237","author":"Tardelli","year":"2020","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.intimp.2023.110210_b0755","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/add.13158","article-title":"Which medications are suitable for agonist drug maintenance?","volume":"111","author":"Darke","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.intimp.2023.110210_b0760","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/nn1105-1431","article-title":"Neurobiology of addiction: treatment and public policy ramifications","volume":"8","author":"Dackis","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0765","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"43","author":"Dackis","year":"2012","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.intimp.2023.110210_b0770","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1360-0443.2008.02437.x","article-title":"A double-blind, placebo-controlled trial of modafinil (200 mg\/day) for methamphetamine dependence","volume":"104","author":"Shearer","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.intimp.2023.110210_b0775","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2014.04.003","article-title":"Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial","volume":"140","author":"Kosten","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.intimp.2023.110210_b0780","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/14760584.2020.1857738","article-title":"Vaccine development against methamphetamine drug addiction","volume":"19","author":"Hossain","year":"2020","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.intimp.2023.110210_b0785","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0140-6736(91)91175-T","article-title":"Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus","volume":"337","author":"Benabid","year":"1991","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.intimp.2023.110210_b0790","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.2402638","article-title":"Reversal of experimental parkinsonism by lesions of the subthalamic nucleus","volume":"249","author":"Bergman","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.intimp.2023.110210_b0795","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(95)90062-4","article-title":"Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation","volume":"345","author":"Limousin","year":"1995","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.intimp.2023.110210_b0800","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/cercor\/bhm167","article-title":"Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression","volume":"18","author":"Johansen-Berg","year":"2008","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.intimp.2023.110210_b0805","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1038\/sj.npp.1301165","article-title":"Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder","volume":"31","author":"Greenberg","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.intimp.2023.110210_b0810","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1212\/WNL.0b013e3181bd809b","article-title":"Thalamic deep brain stimulation for treatment-refractory Tourette syndrome: two-year outcome","volume":"73","author":"Porta","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2023.110210_b0815","article-title":"Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications?","volume":"2009","author":"Kuhn","year":"2009","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.intimp.2023.110210_b0820","doi-asserted-by":"crossref","DOI":"10.1227\/01.NEU.0000360570.40339.64","article-title":"Smoking cessation and weight loss after chronic deep brain stimulation of the nucleus accumbens: therapeutic and research implications: case report","volume":"66","author":"Mantione","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.intimp.2023.110210_b0825","doi-asserted-by":"crossref","DOI":"10.3171\/2018.5.FOCUS18163","article-title":"Deep brain stimulation for the treatment of drug addiction","volume":"45","author":"Wang","year":"2018","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.intimp.2023.110210_b0830","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1176\/ajp.156.1.11","article-title":"Limbic activation during cue-induced cocaine craving","volume":"156","author":"Childress","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.intimp.2023.110210_b0835","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/35084134","article-title":"Incubation of cocaine craving after withdrawal","volume":"412","author":"Grimm","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110210_b0840","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1126\/science.278.5335.45","article-title":"Addiction is a brain disease, and it matters","volume":"278","author":"Leshner","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.intimp.2023.110210_b0845","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nn.3354","article-title":"Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation","volume":"16","author":"Kennedy","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.intimp.2023.110210_b0850","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.euroneuro.2006.10.006","article-title":"Drug addiction: pathways to the disease and pathophysiological perspectives","volume":"17","author":"Le Moal","year":"2007","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923005313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923005313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:30:53Z","timestamp":1785771053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923005313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":170,"alternative-id":["S1567576923005313"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110210","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Future perspectives of emerging novel drug targets and immunotherapies to control drug addiction","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110210"}}